Josep Garcia

Also affiliated with Inhibrx (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation”.

Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation

Journal of Neuro-Oncology(2022)10.1007/s11060-022-04088-3

N/A

0.782DataRank · unranked

16 citations

Jacob Schlossman, Soroush Shabani, Catalina Raymond, Hiroyuki Tatekawa, Lauren E. Abrey +10 more

Depth of radiographic response (DpR) and time to tumor regrowth (TTG) to predict overall survival following anti-VEGF therapy in recurrent glioblastoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2063

N/A

0DataRank · unranked

1 citations

Akifumi Hagiwara, Connor J. Morris, Nicholas S. Cho, Sonoko Oshima, Francesco Sanvito +12 more